These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2238069)

  • 21. Alterations in cyclosporine pharmacokinetics after renal transplantation are linked to rapid increases in hematocrit, lipoproteins, and serum protein.
    Kasiske BL; Awni WM; Heim-Duthoy KL; Rose M; Rao VK; Bloom P; Ney A; Andrisevic J; Odland M; Andersen RC
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):485-6. PubMed ID: 3284094
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacological characteristics of cyclosporin A. Its use in kidney transplantation].
    Obukh IB
    Ter Arkh; 1988; 60(5):136-43. PubMed ID: 3051484
    [No Abstract]   [Full Text] [Related]  

  • 23. Adjustment of cyclosporine dosage in renal transplant patients based on concentration measured specifically in whole blood: clinical outcome results and diagnostic utility.
    Shaw LM; Audet PR; Grossman RA; Fields L; Lensmeyer GL; Dafoe DC
    Transplant Proc; 1990 Jun; 22(3):1267-73. PubMed ID: 2349688
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction of erythromycin with cyclosporine.
    Lysz K; Rosenberg JC; Kaplan MP; Migdal S; Sillix D
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):543-8. PubMed ID: 3284102
    [No Abstract]   [Full Text] [Related]  

  • 25. Interaction of calcium blockers and cyclosporine.
    Wagner K; Henkel M; Heinemeyer G; Neumayer HH
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):561-8. PubMed ID: 3284103
    [No Abstract]   [Full Text] [Related]  

  • 26. Lack of effect of spiramycin on cyclosporin pharmacokinetics.
    Kessler M; Netter P; Renoul HE; Trechot P; Dousset B; Bannwarth B
    Br J Clin Pharmacol; 1990 Mar; 29(3):370-1. PubMed ID: 2360926
    [No Abstract]   [Full Text] [Related]  

  • 27. Covariables in cyclosporine immunosuppression.
    Grevel J; Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1113-5. PubMed ID: 2349671
    [No Abstract]   [Full Text] [Related]  

  • 28. Significance of cyclosporine pharmacokinetics.
    Grevel J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):428-34. PubMed ID: 3284088
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes in the pharmacokinetics of cyclosporine and three of its metabolites in renal transplant patients early in the posttransplant period.
    Awni WM; Kasiske B; Heim-Duthoy K; Rose M; Rao VK; Bloom P; Ney A; Andrisevic J; Odland M; Andersen RC
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):623-4. PubMed ID: 3284111
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclosporine controversies.
    Gerson B
    Clin Lab Med; 1987 Sep; 7(3):669-86. PubMed ID: 3308302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cyclosporine-sparing effects of diltiazem in renal transplantation.
    McCauley J; Ptachcinski RJ; Shapiro R
    Transplant Proc; 1989 Dec; 21(6):3955-7. PubMed ID: 2609415
    [No Abstract]   [Full Text] [Related]  

  • 32. [Nyctohemeral variations of cyclosporine administered orally in renal transplant patients].
    Ramon M; Morel D; Penouil F; Grellet J; Potaux L; Saux MC; Brachet-Liermain A
    Therapie; 1989; 44(5):371-4. PubMed ID: 2814916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of cyclosporine A in bilateral lung transplantation candidates with cystic fibrosis.
    Mancel-Grosso V; Bertault-Peres P; Barthelemy A; Chazalette JP; Durand A; Noirclerc M
    Transplant Proc; 1990 Aug; 22(4):1706-7. PubMed ID: 2389438
    [No Abstract]   [Full Text] [Related]  

  • 34. Aging and drug interactions. III. Individual and combined effects of cimetidine and cimetidine and ciprofloxacin on theophylline metabolism in healthy male and female nonsmokers.
    Loi CM; Parker BM; Cusack BJ; Vestal RE
    J Pharmacol Exp Ther; 1997 Feb; 280(2):627-37. PubMed ID: 9023273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
    Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C;
    Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A longitudinal study of the pharmacokinetics of cyclosporine A and in vitro lymphocyte responses in renal transplant patients.
    Tufveson G; Odlind B; Sjöberg O; Lindberg A; Gabrielsson J; Lindström B; Lithell H; Selinus I; Tötterman T; Wahlberg J
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):16-24. PubMed ID: 2947364
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclosporine pharmacokinetics in a lung transplant patient undergoing hemofiltration.
    Cleary JD; Davis G; Raju S
    Transplantation; 1989 Oct; 48(4):710-2. PubMed ID: 2799932
    [No Abstract]   [Full Text] [Related]  

  • 38. Possible interaction between cyclosporine and erythromycin.
    Kohan DE
    N Engl J Med; 1986 Feb; 314(7):448. PubMed ID: 3511381
    [No Abstract]   [Full Text] [Related]  

  • 39. Sulindac-induced elevation of serum cyclosporine concentration.
    Sesin GP; O'Keefe E; Roberto P
    Clin Pharm; 1989 Jun; 8(6):445-6. PubMed ID: 2663332
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of ponsinomycin on cyclosporin pharmacokinetics.
    Couet W; Istin B; Seniuta P; Morel D; Potaux L; Fourtillan JB
    Eur J Clin Pharmacol; 1990; 39(2):165-7. PubMed ID: 2253667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.